Depleting Trim28 in adult mice is well tolerated and reduces levels of α-synuclein and tau

Alzheimer's and Parkinson's disease are late onset neurodegenerative diseases that will require therapy over decades to mitigate the effects of disease-driving proteins such tau and α-synuclein (α-Syn). Previously we found that TRIM28 regulates the levels and toxicity of α-Syn and tau (Rou...

Descripción completa

Detalles Bibliográficos
Autores principales: Rousseaux, Maxime WC, Revelli, Jean-Pierre, Vázquez-Vélez, Gabriel E, Kim, Ji-Yoen, Craigen, Evelyn, Gonzales, Kristyn, Beckinghausen, Jaclyn, Zoghbi, Huda Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2018
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993537/
https://www.ncbi.nlm.nih.gov/pubmed/29863470
http://dx.doi.org/10.7554/eLife.36768

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993537/
https://www.ncbi.nlm.nih.gov/pubmed/29863470
http://dx.doi.org/10.7554/eLife.36768

Ejemplares similares